Embecta (EMBC) Retained Earnings (2021 - 2026)
Embecta (EMBC) posted Retained Earnings of -$290.0 million for Q1 2026, down 454.52% sequentially from $81.8 million in Q4 2025, and down 546.15% YoY from $65.0 million in Q1 2025.
Embecta (EMBC) Retained Earnings (2021 - 2026) Analysis & Trends
Embecta has reported Retained Earnings for 6 years, with the latest figure at -$290.0 million in Q1 2026.
- Quarterly Retained Earnings fell 546.15% year-over-year to -$290.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$290.0 million (down 546.15% YoY) and the FY2025 annual result came in at -$445.6 million, up 10.63% from the prior year.
- Retained Earnings eased to -$290.0 million in Q1 2026 per EMBC's latest filing, from $81.8 million in the prior quarter.
- Over five years, Retained Earnings peaked at $81.8 million in Q4 2025 and troughed at -$541.1 million in Q3 2023.
- A 5-year average of -$229.8 million and a median of -$290.0 million in 2026 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2023 and 2025: Retained Earnings plunged 5511.0% in 2023, then jumped 116.11% in 2025.
- Over 5 years, Retained Earnings stood at -$298.9 million in 2022, then sank by 77.32% to -$530.0 million in 2023, then advanced by 4.17% to -$507.9 million in 2024, then surged by 116.11% to $81.8 million in 2025, then slumped by 454.52% to -$290.0 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$290.0 million, $81.8 million, and -$445.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 6.84 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 17.51 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 7.26 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 11.40 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 4.62 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 3.92 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 7.70 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 13.81 Bn |
| 10 | Embecta | 319.59 Mn | 101.39 Mn | 153.30 Mn | -404.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -404.30 Mn |
| Mar 31, 2026 | -290.00 Mn |
| Dec 31, 2025 | 81.80 Mn |
| Sep 30, 2025 | -445.60 Mn |
| Jun 30, 2025 | 70.20 Mn |
| Mar 31, 2025 | 65.00 Mn |
| Dec 31, 2024 | -507.90 Mn |
| Sep 30, 2024 | -498.60 Mn |
| Jun 30, 2024 | 46.20 Mn |
| Mar 31, 2024 | -510.00 Mn |
| Dec 31, 2023 | -530.00 Mn |
| Sep 30, 2023 | -541.10 Mn |
| Jun 30, 2023 | -294.70 Mn |
| Mar 31, 2023 | 18.10 Mn |
| Dec 31, 2022 | -298.90 Mn |
| Sep 30, 2022 | 10.00 Mn |
| Jun 30, 2022 | 5.80 Mn |
| Mar 31, 2022 | -286.40 Mn |
| Dec 31, 2021 | -279.30 Mn |
| Sep 30, 2021 | -270.50 Mn |